BURLINGTON, N.C.–(BUSINESS WIRE)–Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2022 before the market opens on Thursday, July 28, 2022. The company will host a conference call and webcast beginning at 9 a.m. EDT that day to discuss the results. The earnings press release … [Read more…]
TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce the closing of its previously-announced acquisition (the “Acquisition”) of Check Five LLC, a Delaware limited liability company (doing business as “Success TMS”) (“Success TMS”). In addition, … [Read more…]
MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX #SkinCancer—MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX) is pleased to announce that it has closed on the First tranche, of $250,000, of the non-brokered Private Placement announced in its Press Release of June 30, 2022. The Placement is to accredited investors of up to a total of $4 million, by … [Read more…]
LEHI, Utah–(BUSINESS WIRE)–This week, Owlet (NYSE: OWLT, “the Company”), the brand that has monitored more than one million babies, announced two new innovations to help parents, and their babies, get better sleep: Predictive Sleep Technology and the Owlet Cam 2. Predictive Sleep Technology is a completely automated sleep tool that tracks a baby’s sleep and … [Read more…]
BURLINGTON, N.C.–(BUSINESS WIRE)–Labcorp (NYSE: LH) (the Company), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 9, 2022, to stockholders of record as of the close of business on August … [Read more…]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the second quarter of 2022 after the close of market on Tuesday, August 2, 2022. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern … [Read more…]
Volker Knappertz, MD, as Executive Vice President, Research and Development, to lead the consolidated R&D function and to further enhance and advance the Aurinia pipeline Scott Habig, as Chief Commercial Officer, to lead and enhance Aurinia’s commercial capabilities, replacing Max Colao, who led the formation of the commercial organization and the launch of Aurinia’s first … [Read more…]
TOKYO–(BUSINESS WIRE)–Elix, Inc., an AI drug discovery company with the mission of “Rethinking Drug Discovery” (CEO: Shinya Yuki/Headquarters: Tokyo; hereafter referred to as “Elix”) launched “Elix Discovery™,” the only all-in-one platform that provides everything needed for AI drug discovery, from models for property prediction and molecular design to AI consulting and implementation support. Drug discovery … [Read more…]
Bipartisan Congressional Delegation Sends Letter to U.S. Department of Health and Human Services Explaining Why North Carolina Is Ideal Location for ARPA-H to Accomplish Its Mission RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Leaders from public and private universities, businesses, nonprofits, trade associations and state government have joined forces to bring the new Advanced Research Projects Agency for … [Read more…]
BOULDER, Colo.–(BUSINESS WIRE)–Enveda Biosciences, a pioneer in transforming small molecule drug discovery by using machine learning and metabolomics to harness the potential of natural products, today announced the appointment of Vanitha Sekar, Ph.D., R.Ph., to the newly created position of Chief Business Officer. Dr. Sekar will play a key role in Enveda’s ongoing growth and … [Read more…]
